These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33571492)
21. Continuing need for and provision of a service for non-standard implant removal. Pillai M; Gazet AC; Griffiths M J Fam Plann Reprod Health Care; 2014 Apr; 40(2):126-32. PubMed ID: 24081828 [TBL] [Abstract][Full Text] [Related]
22. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. Ireland LD; Goyal V; Raker CA; Murray A; Allen RH Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904 [TBL] [Abstract][Full Text] [Related]
24. Etonogestrel implant (Implanon) for contraception. Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801 [TBL] [Abstract][Full Text] [Related]
25. The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience. Creinin MD; Kaunitz AM; Darney PD; Schwartz L; Hampton T; Gordon K; Rekers H Contraception; 2017 Feb; 95(2):205-210. PubMed ID: 27452317 [TBL] [Abstract][Full Text] [Related]
26. [Safety profile of etonogestrel contraceptive implant (Nexplanon Simon C; Agier MS; Béné J; Muller C; Vrignaud L; Marret H; Jonville-Bera AP J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1074-1082. PubMed ID: 27125380 [TBL] [Abstract][Full Text] [Related]
27. Ultrasound localisation of non-palpable Implanon. Piessens SG; Palmer DC; Sampson AJ Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):112-6. PubMed ID: 15760310 [TBL] [Abstract][Full Text] [Related]
28. Compound versus fundamental imaging in the detection of subdermal contraceptive implants. Gabriel H; Shulman L; Marko J; Nikolaidis P; Chirita V J Ultrasound Med; 2007 Mar; 26(3):355-9. PubMed ID: 17324985 [TBL] [Abstract][Full Text] [Related]
29. Minimally-invasive fully ultrasound-guided removal of nonpalpable single-rod contraceptive implant: Case report and technical description. Jacques T; Henry S; Giraudet G; Demondion X; Cotten A Contraception; 2020 May; 101(5):338-341. PubMed ID: 32032638 [TBL] [Abstract][Full Text] [Related]
31. Migration of etonogestrel contraceptive implants: Implications for difficult removals services need in southern Africa. Petro GA; Spence T; Du Plessis JP; Gertz AM; Morroni C S Afr Med J; 2019 Jul; 109(8):559-561. PubMed ID: 31456548 [TBL] [Abstract][Full Text] [Related]
32. Axillary migration of Nexplanon®: Case report. Diego D; Tappy E; Carugno J Contraception; 2017 Feb; 95(2):218-220. PubMed ID: 27865875 [TBL] [Abstract][Full Text] [Related]
33. A risk management approach to the design of contraceptive implants. Rowlands S; Sujan MA; Cooke M J Fam Plann Reprod Health Care; 2010 Oct; 36(4):191-5. PubMed ID: 21067633 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Wenzl R; van Beek A; Schnabel P; Huber J Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383 [TBL] [Abstract][Full Text] [Related]